Silvant Capital Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$416K Hold
2024
Q4
$693K Hold
2024
Q3
$1.09M Hold
2024
Q2
$913K Hold
2024
Q1
$1.41M Buy